Baker Bros. Advisors’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-300,000	Closed	-$4.14M	–	108
2014 Q2	$4.14M	Sell	300,000 -200,000	-40%	-$2.76M	0.05%	76
2014 Q1	$7.66M	Buy	500,000 +399,400	+397%	+$6.11M	0.1%	56
2013 Q4	$813K	Buy	+100,600	New	+$813K	0.01%	90